Literature DB >> 9541826

Therapeutic range of repetitive nanosecond laser exposures in selective RPE photocoagulation.

J Roider1, C Lindemann, H Laqua, R Birngruber.   

Abstract

BACKGROUND: The aim of this study was to investigate whether selective damage the RPE while sparing the adjacent photoreceptors is possible with repetitive 200-ns pulses of Nd:YAG laser (532 nm) and what potential side effects can be expected with higher pulse energies.
METHODS: We irradiated the retinas of 19 eyes of 10 chinchilla rabbits with 500 pulses from a Nd:YAG laser, each 200 ns in duration, at a repetition rate of 500 Hz (158 microns, 0-120 microJ). Threshold curves for different effects were established. Representative lesions were investigated by light and transmission electron microscopy.
RESULTS: It was possible to produce lesions, which were only visible by fluorescein angiography. The ED50 threshold energy per pulse for visibility by fluorescein angiography was 2.1 microJ per pulse, for visibility by ophthalmoscopy 8.6 microJ. Bubble formation, an uncommon phenomenon in retinal photocoagulation, occurred at energies of 15-25 microJ. Hemorrhage occurred at surprisingly high energy levels of more than 100 microJ. Histology performed on lesions visible only by angiography showed damage primarily to the RPE and outer segments, with very little damage to some inner segments dependent on the energy used.
CONCLUSIONS: Selective RPE damage is possible with repetitive 200-ns laser pulses and appropriate energy; however, the collateral damage to the adjacent retina is more pronounced than with repetitive microsecond laser pulses. There is no risk of hemorrhage of retinal photocoagulation with the repetitive 200-ns laser pulses at low energy levels which would be used clinically.

Entities:  

Mesh:

Year:  1998        PMID: 9541826     DOI: 10.1007/s004170050067

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  5 in total

1.  Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study.

Authors:  J Roider; R Brinkmann; C Wirbelauer; H Laqua; R Birngruber
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

2.  Selective retina therapy (SRT) for clinically significant diabetic macular edema.

Authors:  Johann Roider; Shiao Hui Melissa Liew; Carsten Klatt; Hanno Elsner; Erk Poerksen; Jost Hillenkamp; Ralf Brinkmann; Reginald Birngruber
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09       Impact factor: 3.117

3.  Micropulse and continuous wave diode retinal photocoagulation: visible and subvisible lesion parameters.

Authors:  T J Desmettre; S R Mordon; D M Buzawa; M A Mainster
Journal:  Br J Ophthalmol       Date:  2006-03-10       Impact factor: 4.638

4.  Temperature-Controlled Retinal Photocoagulation Reliably Generates Uniform Subvisible, Mild, or Moderate Lesions.

Authors:  Stefan Koinzer; Alexander Baade; Kerstin Schlott; Carola Hesse; Amke Caliebe; Johann Roider; Ralf Brinkmann
Journal:  Transl Vis Sci Technol       Date:  2015-10-06       Impact factor: 3.283

5.  Retinal safety evaluation of photoacoustic microscopy.

Authors:  Yanxiu Li; Wei Zhang; Van Phuc Nguyen; Naheed Wali Khan; Xiaobo Xia; Xueding Wang; Yannis M Paulus
Journal:  Exp Eye Res       Date:  2020-11-24       Impact factor: 3.467

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.